# Novitium Pharma LLC – FDA Inspection, Feb 4, 2019

Source: https://www.keypedia.com/records/fda_inspections/novitium-pharma-llc/39280e41-44ce-4cff-83ec-fff6aa1e07c5
Source feed: FDA_Inspections

> FDA inspection 1080904 of Novitium Pharma LLC, February 04, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1080904
- Company Name: Novitium Pharma LLC
- Inspection Date: 2019-02-04
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1230049 - 2024-02-16
- FDA Inspection 1231393 - 2024-02-01
- [FDA Inspection 1204308 - 2023-03-31](https://www.keypedia.com/records/fda_inspections/novitium-pharma-llc/071be200-4a09-4449-947c-fe0d400d5cc8)
- FDA Inspection 1145707 - 2021-07-08
- FDA Inspection 1067953 - 2018-09-11

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/frederick-razzaghi/7346f6ec-1d9a-4ad3-abde-0497dcd9c8b5)

Company: https://www.keypedia.com/companies/novitium-pharma-llc/056d60b0-f42a-4b34-987f-749ffff0520a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
